Diatomite silica nanoparticles for drug delivery
© Ruggiero et al.; licensee Springer. 2014
Received: 18 April 2014
Accepted: 20 June 2014
Published: 3 July 2014
Diatomite is a natural fossil material of sedimentary origin, constituted by fragments of diatom siliceous skeletons. In this preliminary work, the properties of diatomite nanoparticles as potential system for the delivery of drugs in cancer cells were exploited. A purification procedure, based on thermal treatments in strong acid solutions, was used to remove inorganic and organic impurities from diatomite and to make them a safe material for medical applications. The micrometric diatomite powder was reduced in nanoparticles by mechanical crushing, sonication, and filtering. Morphological analysis performed by dynamic light scattering and transmission electron microscopy reveals a particles size included between 100 and 300 nm. Diatomite nanoparticles were functionalized by 3-aminopropyltriethoxysilane and labeled by tetramethylrhodamine isothiocyanate. Different concentrations of chemically modified nanoparticles were incubated with cancer cells and confocal microscopy was performed. Imaging analysis showed an efficient cellular uptake and homogeneous distribution of nanoparticles in cytoplasm and nucleus, thus suggesting their potentiality as nanocarriers for drug delivery.
87.85.J81.05.Rm; 61.46. + w
KeywordsDiatomite Porous silica nanoparticle Drug delivery system Surface modification
Modern medicine has been revolutionized by the use of micro/nanocarriers that, acting theoretically as ‘magic bullets’ , operate in site-specific delivery mechanism to spare normal cells and tissues. A kind of natural microcarriers developed for innovative drug delivery is represented by diatomite silica microparticles . Diatomite is a fossil material of sedimentary origin formed by fragments of diatom skeletons, called frustules. Frustules of diatoms, single-cell photosynthetic algae largely diffused in aquatic environments, are mainly constituted by amorphous silica and are characterized by a specific surface area up to 200 m2/g . In nature, there are different kinds of diatoms (about 110,000 species) varying in size (from 2 μm to 2 mm) and morphology . The low cost, abundance, easy availability, excellent biocompatibility, non-toxicity, thermal stability, and chemical inertness make diatomite an intriguing material for several applications ranging from filtration to pharmaceutics [5–8]. Diatomite is composed by 70 to 90% of silica, clay, some metallic oxides, such as Al2O3 and Fe2O3, and other organic components . Usually, diatomite mined from geological deposits must be purified before to be used; thermal pre-calcination and HCl washing are the treatments generally used to increase powder quality and to make the biomaterial inert as filter support [9, 10]. The diatomite silica surface presents reactive Si-OH groups that can be chemically modified in order to achieve a functionalized surface with proper chemical groups, such as − NH2, −COOH, −SH, and − CHO, which can be used for small interfering RNA (siRNA), microRNA (miRNA), decoy oligo, and drug loading [11, 12].
In the present work, diatomite nanoparticles (DNPs) with a diameter lower than 300 nm were prepared by mechanical crushing, sonication, and filtering of micrometric diatomite powder. Nanoparticles, once purified from organic and inorganic impurities, were functionalized by using 3-aminopropyltriethoxysilane (APTES) and labeled with tetramethylrhodamine isothiocyanate (TRITC) in order to verify their cellular uptake. Confocal microscopy was used to investigate nanocarrier internalization in lung epidermoid cancer cells (H1355). Results demonstrated effective cellular uptake of nanoparticles and highlighted their potentiality in nanomedicine as carriers able to improve drug delivery.
Calcined diatomite was obtained by DEREF S.p.A (Castiglione in Teverina, Viterbo, Italy). 3-aminopro-pyltriethoxysilane (APTES), H2SO4, and tetramethylrhodamine isothiocyanate (TRITC) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Phosphate-buffered saline (PBS) was purchased from GIBCO (Carlsbad, CA, USA). HCl was purchased from Romil (Cambridge, UK). Absolute ethanol and H2O2 was purchased from Carlo Erba (Milan, Italy); HEPES powder was purchased from Promega (Madison, WI, USA).
Purification of diatomite powder
Five grams of crashed diatomite rocks were resuspended into 250 ml of absolute ethanol and sonicated for 5 h to break large aggregates. The dispersion was sieved through a nylon net filter with pore size of 41 μm, and then filtered with pore size of 0.45 μm (Millipore, Billerica, MA, USA). The diatomite nanopowder was purified to remove organic and inorganic impurities [9, 10]. The sample was centrifuged and the pellet treated with Piranha solution (2 M H2SO4, 10% H2O2) for 30 min at 80°C. Nanoparticle dispersion was centrifuged for 30 min at 21,500 × g, washed twice with distilled water, resuspended in 5 M HCl, and incubated over night at 80°C. DNPs were then centrifuged for 30 min at 21,500 × g and washed twice with distilled water to eliminate HCl residues.
Characterization of nanoparticles size
The size and zeta-potential measurements of purified diatomite nanoparticles dispersed in water (pH = 7) were performed before and after APTES functionalization by dynamic light scattering (DLS) using a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK) equipped with a He-Ne laser (633 nm, fixed scattering angle of 173°, 25°C).
Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) were also used to investigate nanoparticles morphology. Briefly, in TEM analysis, purified diatomite nanoshells were characterized by placing a drop of suspension on a TEM copper grid with a lacy carbon film and then observed by a Jeol 1011 TEM (Peabody, MA, USA) at an accelerating voltage of 100 KV. For SEM characterization, diatomite samples were deposited on crystalline silicon substrates mounted on a double-faced conductive adhesive tape. Images were acquired at 5-kV accelerating voltage and 30-μm wide aperture.
The human lung epidermoid cancer cell line (H1355), obtained from American Type Tissue Collection (Rockville, MD, USA), was grown at 37°C with an atmosphere of 5% CO2, in RPMI 1640 (GIBCO) medium supplemented with 10% heat inactivated FBS (GIBCO), 100 U/mL penicillin, 100 mg/mL streptomycin, 1% l-glutamine.
Purified nanoparticles were amino-modified with a 5% (v/v) APTES solution in absolute ethanol [13, 14]. The APTES film formation was carried out for 1 h at room temperature with stirring in a dark condition. After this step, the sample was centrifuged for 30 min at 21,500 × g and supernatant discarded. The functionalized diatomite were washed twice with absolute ethanol and the collected pellet was incubated for 10 min at 100°C (curing process). Finally, the sample was washed twice with absolute ethanol and twice with 20 mM HEPES buffer pH 7.5.
Fourier-transform infrared spectroscopy
Chemical composition of APTES-functionalized diatomite nanoparticles was analyzed by Fourier-transform infrared (FTIR) spectroscopy. Spectra were recorded by a Thermo-Nicholet NEXUS Continuum XL (Thermo Scientific, Waltham, MA, USA) equipped with a microscope, at 2 cm−1 resolution on samples deposited on silicon chips (p-type, 0.003 ohm cm resistivity, <100 > oriented, 500-μm tick) of about 1 cm × 1 cm.
Nanopowder diatomite labeling
Diatomite labeling procedure was based on the use of an aminoreactive molecule, tetramethylrhodamine isothiocyanate. TRITC powder was solved in dimethyl sulfoxide (DMSO) and incubated with diatomite nanopowder in the presence of NaHCO3 0.1 M pH 8.7 with stirring for 1 h at room temperature in a dark condition. Subsequently, the sample was washed with distilled water to remove TRITC excess, until no fluorescence was revealed in the supernatant when analyzed by fluorescence microscopy. Labeled diatomite nanoparticles will be indicated as DNPs*.
H1355 cell line (20 × 103 cells/coverslip) was plated on 10-mm glass coverslips placed on the bottom of 24-well plate, allowed to attach for 24 h under normal cell culture conditions, and then incubated with increasing DNPs* concentration (5, 10, 15 μg/mL) for 24 h. As negative control, the last supernatant obtained from nanoparticles labeling procedure was added to the cells. Cell nuclei and membranes were then stained with Hoechst 33342 (Invitrogen, Carlslab, CA, USA) and WGA-Alexa Fluor 488, respectively. Images were acquired at × 63 magnification on a LSM710 confocal fluorescence microscope (Carl Zeiss Inc., Peabody, MA, USA) with the appropriate filters. Cell fluorescence intensity was analyzed by using ImageJ software (http://imagej.nih.gov/ij/).
Results and discussion
Characterization of diatomite nanoparticles
Diatomite powder functionalization
APTES-modified silica nanoparticles dispersed in water (pH = 7) were also characterized by DLS analysis. A size of 280 ± 50 nm and a zeta-potential of +80 ± 5 mV were determined (data not shown). The positive potential is the result of protonation of amino groups on nanoparticles surface .
Confocal microscopy analysis and DNPs* internalization
In this work, a procedure for preparing diatomite nanoparticles with an average size of 200 nm was described. DNP morphology and surface chemical modifications were investigated by DLS, SEM and TEM, and FTIR analyses, respectively. Confocal microscopy experiments revealed an efficient nanoparticle uptake into cytoplasm of human epidermoid carcinoma cells. This preliminary study demonstrates that the diatomite nanoparticles could represent a promising tool for the delivery of anticancer molecules such as siRNA, miRNA, and drugs inside cancer cells. Since APTES functionalization of the nanoparticles showed the possibility to efficiently bind amino-reactive groups (TRITC), the development of chemical protocols for loading anticancer molecules represents a further step in order to finalize the use of diatomite in medical applications. Moreover, it would be expected that compared to other nanocarriers, their selective targeted functionalization will improve the delivery of anti-tumoral molecules to specific cell population.
The authors thank the DEREF S.p.A. for kindly providing the diatomite earth sample. The authors also thank S. Arbucci of the IGB-CNR Integrated Microscopy Facility for the assistance with confocal microscopy acquisition and Dr. P. Dardano of the IMM-CNR for the SEM analysis. This work has been partially supported by Italian National Operative Program PON01_02782 and POR Campania FSE 2007-2013, Project CRÈME.
- Mai WX, Meng H: Mesoporous silica nanoparticles: a multifunctional nano therapeutic system. Integr Biol 2013, 5: 19–28. 10.1039/c2ib20137bView Article
- Zhang H, Shahbazi MA, Mäkilä EM, da Silva TH, Reis RL, Salonen JJ, Hirvonen JT, Santos HA: Diatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamine. Biomaterials 2013, 34: 9210–9219. 10.1016/j.biomaterials.2013.08.035View Article
- Şan O, Gören R, Özgür C: Purification of diatomite powder by acid leaching for use in fabrication of porous ceramics. Int J Miner Process 2009, 93: 6–10. 10.1016/j.minpro.2009.04.007View Article
- Wang Y, Cai J, Jiang Y, Jiang X, Zhang D: Preparation of biosilica structures from frustules of diatoms and their applications: current state and perspectives. Appl Microbiol Biotechnol 2013, 97: 453–462. 10.1007/s00253-012-4568-0View Article
- Xiaohua Q, Mingzhu L, Zhenbin C, Rui L: Preparation and properties of diatomite composite superabsorbent. Polym Adv Technol 2007, 18: 184–193. 10.1002/pat.847View Article
- Carter MJ, Milton ID: An inexpensive and simple method for DNA purifications on silica particles. Nucleid Acids Res 1993, 21: 1044. 10.1093/nar/21.4.1044View Article
- Khraisheh MA, Al-Ghouti MA, Allen SJ, Ahmad MN: Effect of OH and silanol groups in the removal of dyes from aqueous solution using diatomite. Water Res 2005, 39: 922–932. 10.1016/j.watres.2004.12.008View Article
- Aw MS, Simovic S, Yu Y, Addai-Mensah J, Losic D: Porous silica microshells from diatoms as biocarrier for drug delivery applications. Powder Technol 2012, 223: 52–58.View Article
- Goren R, Baykara T, Marsoglu M: A study on the purification of diatomite in hydrochloric acid. Scand J Metall 2002, 31: 115–119. 10.1034/j.1600-0692.2002.310205.xView Article
- Goren R, Baykare T, Marsoglu M: Effects of purification and heat treatment on pore structure and composition of diatomite. Br Ceramic Trans 2002, 101: 177–180. 10.1179/096797802225003361View Article
- Bariana M, Aw MS, Kurkuri M, Losic D: Tuning drug loading and release properties of diatom silica microparticles by surface modifications. Int J Pharm 2013, 443: 230–241. 10.1016/j.ijpharm.2012.12.012View Article
- Losic D, Yu Y, Aw MS, Simovic S, Thierry B, Addai-Mensah J: Surface functionalisation of diatoms with dopamine modified iron-oxide nanoparticles: toward magnetically guided drug microcarriers with biologically derived morphologies. ChemComm 2010, 46: 6323–6325.
- De Stefano L, Lamberti A, Rotiroti L, De Stefano M: Interfacing the nanostructured biosilica microshells of the marine diatom Coscinodiscus wailesii with biological matter. Acta Biomater 2008, 4: 126–130. 10.1016/j.actbio.2007.09.003View Article
- De Stefano L, Rotiroti L, De Stefano M, Lamberti A, Lettieri S, Setaro A, Maddalena P: Marine diatoms as optical biosensors. Biosens Bioelectron 2009, 24: 1580–1584. 10.1016/j.bios.2008.08.016View Article
- Sailor MJ, Park J-H: Hybrid nanoparticles for detection and treatment of cancer. Adv Mater 2012, 24: 3779–3802. 10.1002/adma.201200653View Article
- Kim J, Seidler P, Wan LS, Fill C: Formation, structure, and reactivity of amino-terminated organic films on silicon substrates. J Colloid Interface Sci 2009, 329: 114–119. 10.1016/j.jcis.2008.09.031View Article
- Chiang CH, Ishida H, Koenig JL: The structure of γ-aminopropyltriethoxysilane on glass surfaces. J Colloid Interf Sci 1980, 2: 396.View Article
- Cheang TY, Tang B, Xu AW, Chang GQ, Hu ZJ, He WL, Xing ZH, Xu JB, Wang M, Wang SM: Promising plasmid DNA vector based on APTES modified silica nanoparticles. Int J Nanomedicine 2012, 7: 1061–1067.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.